The Scientist

» drug development and neuroscience

Most Recent

image: Eyes Track Dream Scenes

Eyes Track Dream Scenes

By | August 13, 2015

In vivo recordings from humans reveal that brain activity related to seeing pictures correlates with eye movements during REM sleep.

0 Comments

image: Fruit-Fly Neurons in Action

Fruit-Fly Neurons in Action

By | August 12, 2015

Researchers visualize the complete nervous system of a Drosophila melanogaster larva at nearly single-neuron resolution.

0 Comments

image: Doctor Who Blocked Thalidomide Dies

Doctor Who Blocked Thalidomide Dies

By | August 11, 2015

Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.

0 Comments

image: Bacterial Enzyme an Antismoking Aid?

Bacterial Enzyme an Antismoking Aid?

By | August 10, 2015

A compound that degrades nicotine before it reaches the brain could serve as a successful smoking cessation therapy, according to an in vitro study.

0 Comments

image: Chemical Cocktails Produce Neurons

Chemical Cocktails Produce Neurons

By | August 6, 2015

Two research groups have devised small-molecule recipes to directly transform fibroblasts into neurons.

0 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.

0 Comments

image: Cognitive Decline More Swift in Women

Cognitive Decline More Swift in Women

By | July 22, 2015

Mental agility in women deteriorates at twice the rate of that in men, according to a study of people with mild cognitive impairment.

0 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. National Academies Detail the State of Weed Science
  3. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  4. Trumping Science: Part III
    The Nutshell Trumping Science: Part III

    Scientists criticize unconfirmed reports that President-elect Donald Trump has asked Robert Kennedy Jr., an anti-vaccine activist, to investigate vaccine safety.

RayBiotech